Arrhythmogenic right ventricular dysplasia (ARVD), also known as arrhythmogenic right ventricular cardiomyopathy (ARVC), requires careful and thorough evaluation to identify life-threatening heart rhythm problems before they cause serious harm. Early diagnosis through specialized tests can help protect young people and athletes from sudden cardiac events and guide families toward proper screening and care.

Introduction: Who Needs Diagnostic Testing for ARVD

Knowing when to seek diagnostic testing for arrhythmogenic right ventricular dysplasia can make the difference between life and death. This condition often hides quietly in the body, causing no obvious problems until a dangerous heart rhythm suddenly appears. Because of this hidden nature, certain people should undergo testing even when they feel completely healthy.^[1]

If you have a close family member with ARVD, you should consider getting checked. This includes parents, siblings, children, grandchildren, uncles, aunts, nephews, and nieces of someone diagnosed with the condition. All relatives who are teenagers or older should see a healthcare provider for evaluation, regardless of whether they have symptoms. This is because ARVD runs in families, and up to half of all cases have a family history of the disease.^[1]

Young people who experience certain warning signs should seek diagnostic testing right away. These signs include fainting spells, especially during exercise or physical activity, feelings of a racing or fluttering heartbeat, unexplained chest pain, or unusual shortness of breath during activities that previously felt easy. Dizziness or lightheadedness during sports or exertion also warrants medical attention.^[1]

Athletes and physically active young adults need to pay special attention to these symptoms. ARVD is the second most common cause of sudden cardiac death in young people, particularly those involved in competitive sports. After a condition called hypertrophic cardiomyopathy, ARVD accounts for about 10 percent of sudden cardiac deaths in people under 65 years of age.^[4]

Sometimes, tragically, sudden cardiac death can be the very first sign of ARVD, occurring without any previous symptoms. This happens because many people with the condition develop dangerous irregular heart rhythms that start in the lower chambers of the heart, called ventricular arrhythmias. These abnormal rhythms can be life-threatening even before a person knows they have the disease.^[1]

Classic Diagnostic Methods for ARVD

Diagnosing arrhythmogenic right ventricular dysplasia is challenging because the condition can look different from person to person and its symptoms overlap with other heart problems. Doctors must use a combination of different tests and clinical observations to make an accurate diagnosis. The approach involves looking at the heart’s structure, its electrical activity, how well it pumps blood, and sometimes examining the genetic makeup of the patient.^[3]

Electrocardiogram (ECG or EKG)

An electrocardiogram, commonly called an ECG or EKG, is usually one of the first tests performed when ARVD is suspected. This test records the electrical signals that control your heartbeat. Small sticky patches called electrodes are placed on your chest, arms, and legs, and they pick up the electrical activity from your heart. The test is painless and takes only a few minutes.^[1]

In people with ARVD, the ECG often shows specific patterns that suggest the disease. About 85 percent of patients have flipped or inverted T waves in the right side chest leads, specifically in positions called V1 through V3. This happens when there is no other reason for these changes, such as a condition called right bundle branch block.^[4]

One of the most specific findings on an ECG for ARVD is something called an epsilon wave. This is a small extra wave that appears after the main heartbeat signal. It occurs because of delayed electrical conduction in the right ventricle. About half of patients with ARVD show this epsilon wave, making it a strong indicator of the disease when present.^[4]

The ECG may also reveal other changes typical of ARVD, including a widening of the electrical signal in certain chest leads, taking longer than 110 milliseconds to complete. The upward movement of a part of the signal called the S wave may be prolonged, taking 55 milliseconds or more in specific chest positions. Additionally, the heart may show extra beats that have an unusual pattern, with more than 1,000 abnormal beats occurring in a 24-hour period.^[4]

Holter Monitor and Event Monitoring

Because abnormal heart rhythms in ARVD may come and go, doctors often use monitoring devices that record your heart’s electrical activity over longer periods. A Holter monitor is a portable device you wear for 24 hours or longer. It continuously records your heart rhythm while you go about your normal daily activities. This extended recording can catch irregular heartbeats that might not show up during a brief office visit.^[5]

Event monitors are similar devices but are typically worn for weeks or even months. They record your heart rhythm only when you press a button because you feel symptoms, or they automatically record when they detect an abnormal rhythm. These longer monitoring periods increase the chance of capturing the episodic ventricular tachycardia—a rapid heart rhythm starting in the ventricles—that is common in ARVD.^[1]

Echocardiography

An echocardiogram, or echo for short, uses sound waves to create moving pictures of your heart. A technician places a wand-like device called a transducer on your chest, which sends sound waves through your body. These waves bounce off your heart structures and return to create images on a screen. The test is painless and does not use radiation.^[5]

Echocardiography is often the first imaging test ordered when ARVD is suspected. It can show whether the right ventricle has become enlarged, stretched out, or thinned. The test can reveal areas where the heart wall moves abnormally or contracts poorly. Doctors can also see if there are prominent muscle bands inside the right ventricle or if the outflow tract—the area where blood exits the right ventricle—has become abnormally wide.^[4]

While echocardiography is helpful, it has limitations in diagnosing ARVD. The right ventricle has a complex shape that makes it difficult to see all areas clearly with standard ultrasound. Sometimes, the changes in the heart are subtle and hard to distinguish from normal variations, especially in athletes whose hearts naturally adapt to exercise.^[5]

Cardiac Magnetic Resonance Imaging (MRI)

Cardiac magnetic resonance imaging, or cardiac MRI, has become the preferred imaging test for diagnosing ARVD in many medical centers. This test uses powerful magnets and radio waves to create detailed pictures of the heart’s structure and function. Unlike echocardiography, cardiac MRI can visualize the right ventricle from all angles and can detect the fatty or fibrous tissue that replaces normal heart muscle in ARVD.^[4]

During a cardiac MRI, you lie inside a tube-shaped machine for about 45 to 90 minutes. The machine is noisy, but you can wear earplugs. You must stay still during the scan so the images are clear. Sometimes, a contrast dye is injected into your vein to help certain heart structures show up better. This dye can highlight areas of scar tissue in the heart muscle.^[5]

Cardiac MRI can accurately show several key features of ARVD. It reveals fatty or fibrous infiltration in the heart muscle, thinning of the right ventricle wall, bulging areas called aneurysms, enlargement of the right ventricle, abnormal wall motion in specific regions, and overall pumping problems. These detailed images help doctors distinguish ARVD from other conditions that might cause similar symptoms.^[4]

Right Ventriculography

Right ventriculography is an invasive test performed during cardiac catheterization. During this procedure, a doctor threads a thin, flexible tube called a catheter through a blood vessel, usually in your groin or neck, and guides it into your heart. Once the catheter is in the right ventricle, contrast dye is injected, and X-ray movies are taken to see how the chamber moves and functions.^[5]

This test can show the characteristic features of ARVD, including areas of the right ventricle that bulge outward (aneurysms), regions where the wall moves abnormally or not at all, and overall enlargement of the chamber. While very accurate, right ventriculography is invasive and carries small risks, so it is typically reserved for cases where other tests have not provided clear answers.^[5]

Endomyocardial Biopsy

An endomyocardial biopsy involves taking tiny tissue samples from the inside of the heart muscle. Like right ventriculography, this is done through cardiac catheterization. A special catheter with a small cutting device at its tip is guided into the right ventricle, where it removes several small pieces of heart tissue. These samples are then examined under a microscope to look for the characteristic replacement of normal heart muscle with fatty or fibrous tissue.^[4]

While endomyocardial biopsy can provide a definitive diagnosis when it shows the typical tissue changes, it has significant limitations. The disease often affects the heart in patches, meaning the biopsy might miss diseased areas and sample only healthy tissue. The procedure also carries risks, including the possibility of puncturing the heart wall. For these reasons, endomyocardial biopsy is not routinely performed and is usually reserved for very uncertain cases.^[4]

Electrophysiology Studies

An electrophysiology study, or EP study, examines the heart’s electrical system in detail. During this test, catheters are inserted through blood vessels and positioned inside the heart. These catheters can record electrical signals from specific areas and can also stimulate the heart to trigger abnormal rhythms in a controlled environment. This helps doctors understand what types of arrhythmias a patient is prone to and where they originate.^[5]

Electrophysiology studies can help distinguish ARVD from other conditions that cause ventricular tachycardia. They can also assess how easily dangerous rhythms can be triggered and help guide treatment decisions. For instance, if a patient’s ventricular tachycardia can be reliably induced during the study, doctors know the person is at higher risk and may need more aggressive treatment.^[5]

Genetic Testing

Since ARVD is usually caused by changes in genes, genetic testing plays an important role in diagnosis and family screening. A simple blood test can analyze your DNA to look for mutations in the genes known to cause ARVD. Researchers have identified at least 13 different genes with variations that can lead to this condition.^[1]

Genetic testing is especially valuable when someone in your family has already been diagnosed with ARVD. If doctors find the specific genetic mutation responsible for the disease in your relative, other family members can be tested for that same mutation. This makes screening much more straightforward. Even if you have the mutation but show no symptoms, your doctor can monitor you closely and start protective treatments if needed.^[1]

However, genetic testing has limitations. Not everyone with ARVD has a detectable genetic mutation with current testing methods. Additionally, having a gene mutation does not always mean you will develop significant symptoms—the severity and age of onset can vary greatly even within the same family. Genetic counselors can help you understand what your test results mean for you and your family members.^[1]

The 2010 Task Force Criteria

Because no single test can definitively diagnose ARVD, doctors use a set of guidelines called the 2010 Task Force Criteria. These criteria combine findings from ECGs, imaging tests, heart rhythm abnormalities, tissue samples, and family history. Each finding is classified as either a major or minor criterion based on how specific it is for ARVD.^[4]

To diagnose ARVD, a patient must meet one of the following combinations: two major criteria, one major plus two minor criteria, or four minor criteria. This system helps doctors make accurate diagnoses while avoiding misdiagnosing people who have other conditions or normal variations in their hearts. The criteria were revised in 2020 to better recognize that ARVD can also affect the left ventricle and septum, not just the right ventricle.^[3]

Diagnostics for Clinical Trial Qualification

When patients with ARVD consider enrolling in clinical trials testing new treatments, they must undergo specific diagnostic tests to determine if they qualify. Clinical trials have strict entry criteria to ensure that participants actually have the condition being studied and that it is safe for them to receive experimental treatments. These qualification tests are typically more detailed and standardized than routine diagnostic procedures.^[3]

Most clinical trials for ARVD require confirmation of the diagnosis using the 2010 Task Force Criteria or the revised 2020 criteria. Potential participants must provide documentation showing they meet the required number of major and minor criteria. This typically includes copies of ECG reports showing characteristic changes like T wave inversions or epsilon waves, imaging studies such as cardiac MRI or echocardiogram reports demonstrating structural abnormalities of the right ventricle, and records of documented arrhythmias captured on monitors or during electrophysiology studies.^[3]

Genetic testing is often required or strongly encouraged for clinical trial participants. Trials studying genetic therapies or trying to understand how different gene mutations affect disease progression need to know each participant’s genetic status. Blood samples are collected and analyzed for mutations in the genes known to cause ARVD. This information helps researchers group participants by their genetic profiles and understand whether experimental treatments work better for certain genetic types.^[1]

Cardiac MRI has become a standard requirement for many ARVD clinical trials. This imaging technique provides the most detailed and reproducible measurements of right ventricular size, function, and tissue characteristics. Trials use standardized MRI protocols to ensure that all participants are evaluated the same way at different medical centers. Baseline MRI scans taken before treatment begins are compared to follow-up scans during and after treatment to measure whether experimental therapies slow disease progression or improve heart function.^[4]

Holter monitoring for 24 to 48 hours is commonly required to document the burden of arrhythmias before enrolling in trials testing anti-arrhythmic drugs or ablation techniques. The recording captures how many abnormal heartbeats occur over a full day and night, providing a baseline measurement. After treatment, repeat Holter monitoring shows whether the experimental therapy reduced the number of dangerous heart rhythms.^[5]

Exercise testing may be part of the screening process for clinical trials. ARVD symptoms often worsen during physical activity, and exercise can trigger arrhythmias. During a supervised exercise test, patients walk or run on a treadmill while their heart rhythm and blood pressure are continuously monitored. This test helps identify people whose arrhythmias are exercise-induced and measures their exercise capacity, which can be an important outcome in trials testing treatments meant to improve quality of life.^[1]

Blood tests checking kidney and liver function are standard requirements because many experimental drugs are processed by these organs. If your kidneys or liver are not working properly, you might not be able to safely participate in a trial testing a new medication. Similarly, pregnancy tests are required for women of childbearing age, as most experimental treatments cannot be given during pregnancy due to unknown effects on the developing baby.^[5]

Electrophysiology studies might be required for certain trials, particularly those testing ablation techniques or implantable device therapies. These invasive studies help researchers understand the electrical properties of each participant’s heart and locate the origins of abnormal rhythms. While not comfortable, these studies provide detailed information that helps match participants to the most appropriate experimental treatments.^[5]

Quality of life questionnaires and functional assessments are increasingly used in clinical trials. These standardized surveys ask about symptoms like shortness of breath, fatigue, chest pain, and palpitations, and how these symptoms affect daily activities. Researchers use this information to understand whether experimental treatments not only improve test results but also make patients feel better and live more normally.^[3]

Documentation of previous treatments is essential for trial enrollment. Researchers need to know what medications you have tried, whether you have an implantable cardioverter-defibrillator device, and if you have undergone catheter ablation procedures in the past. This history helps determine whether you meet the criteria for trials testing treatments for patients who have not responded to standard therapies.^[5]